Evidence map›Paper›PMID 34681512›Full record

ArticleFoods (Basel, Switzerland)2021

Storage Proteins Are Driving Pediatric Hazelnut Allergy in a Lipid Transfer Protein-Rich Area.

Teresa Valbuena, Marta Reche, Guadalupe Marco, Inmaculada Toboso, Anna Ringauf, Israel J Thuissard-Vasallo, Daniel Lozano-Ojalvo, Mónica Martínez-Blanco, Elena Molina

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Teresa ValbuenaAllergology Department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain.
Marta RecheAllergology Department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain.
Guadalupe MarcoAllergology Department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain.
Inmaculada TobosoImmunology, Laboratorio Central UR Salud Madrid, San Sebastián de los Reyes, 28702 Madrid, Spain.
Anna RingaufMacro Array Diagnostics, 1230 Wien, Austria.
Israel J Thuissard-VasalloFaculty of Biomedical and Health Science, Universidad Europea de Madrid, 28670 Madrid, Spain.ORCID 0000-0002-6990-0619
Daniel Lozano-OjalvoIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-3524-2929
Mónica Martínez-BlancoInstituto de Investigación en Ciencias de la Alimentación (CIAL) (CSIC-UAM), 28049 Madrid, Spain.ORCID 0000-0003-1153-7957
Elena MolinaInstituto de Investigación en Ciencias de la Alimentación (CIAL) (CSIC-UAM), 28049 Madrid, Spain.ORCID 0000-0001-7918-7768
Hospital Universitario Infanta Sofía · ESInstituto de Investigación en Ciencias de la Alimentación · ESIcahn School of Medicine at Mount Sinai · USMadrid Health Service · ESUniversidad Europea de Madrid · ES

Funding

Fundación SEAIC año 2016
6 · The paper itself

Abstract

Oral food challenge (OFC) remains the gold standard for the diagnosis of food allergies. However, this test is not without risks, given that severe allergic reactions can be triggered while it is conducted. The purpose of this study is to identify potential demographic variables, clinical characteristics of the patients and biomarkers that may be associated with severe reactions during the hazelnut oral challenge test. The sample included 22 children allergic to hazelnut who underwent a tree nut skin prick test (SPT), specific IgE (sIgE) to hazelnut, component-resolved diagnosis (CRD) with different hazelnut allergens (Cor a 1, Cor a 8, Cor a 9, Cor a 11, Cor a 14), and a single-blind placebo-controlled challenge with hazelnut. A statistically significant relationship was found between the severity of the reaction and the highest values of sIgE to hazelnut, Cor a 11 and Cor a 14, cumulative symptom-triggering dose and sunflower seed sensitization. The use of the CRD is a useful tool to identify patients at higher risk of developing a severe reaction. In this pediatric population sample from Spain, storage proteins were confirmed to be most involved in hazelnut allergy and the development of severe reactions.

Indexed as

component-resolved diagnosisfood challengehazelnut allergyseverityskin-prick testspecific IgE

Identifiers

PMID34681512
PMCPMC8535272
OpenAlexW3205457548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.